463 related articles for article (PubMed ID: 27837164)
21. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.
Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B
J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342
[TBL] [Abstract][Full Text] [Related]
22. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation.
Sulkowski JP; Preston TJ; Cooper JN; Duffy VL; Deans KJ; Chicoine LG; Minneci PC
J Extra Corpor Technol; 2014 Mar; 46(1):69-76. PubMed ID: 24779122
[TBL] [Abstract][Full Text] [Related]
23. Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation.
Park JH; Her C; Min HK; Kim DK; Park SH; Jang HJ
Int J Artif Organs; 2015 Nov; 38(11):595-9. PubMed ID: 26728787
[TBL] [Abstract][Full Text] [Related]
24. Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin-based anticoagulation in intensive care patients on extracorporeal membrane oxygenation.
Prakash S; Wiersema UF; Bihari S; Roxby D
Anaesth Intensive Care; 2016 Jan; 44(1):85-92. PubMed ID: 26673593
[TBL] [Abstract][Full Text] [Related]
25. Anti-factor Xa vs aPTT for heparin monitoring in extracorporeal membrane oxygenation.
Vo T; Bello A; Ragan M; Flanagan J; Johnson D
Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S77-S83. PubMed ID: 36478046
[TBL] [Abstract][Full Text] [Related]
26. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
[TBL] [Abstract][Full Text] [Related]
27. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: A systematic review and meta-analysis.
Mazzeffi M; Lin D; Gonzalez-Almada A; Stombaugh DK; Curley J; Mangunta V; Teman N; Yarboro LT; Thiele R
Perfusion; 2024 Apr; 39(3):525-535. PubMed ID: 36595340
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.
Tang S; Xu L; Li H; Wu Z; Wen Q
Eur J Clin Pharmacol; 2023 Dec; 79(12):1583-1594. PubMed ID: 37740749
[TBL] [Abstract][Full Text] [Related]
30. Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multicenter Study.
Piwowarczyk P; Borys M; Kutnik P; Szczukocka M; Sysiak-Sławecka J; Szułdrzyński K; Ligowski M; Drobiński D; Czarnik T; Czuczwar M
ASAIO J; 2021 Jan; 67(1):104-111. PubMed ID: 32404610
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.
Arnouk S; Altshuler D; Lewis TC; Merchan C; Smith DE; Toy B; Zakhary B; Papadopoulos J
ASAIO J; 2020 Mar; 66(3):300-306. PubMed ID: 31045921
[TBL] [Abstract][Full Text] [Related]
32. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
[TBL] [Abstract][Full Text] [Related]
33. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
Muntean W
Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
[TBL] [Abstract][Full Text] [Related]
34. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
Dager WE; Gosselin RC; Yoshikawa R; Owings JT
Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
[TBL] [Abstract][Full Text] [Related]
35. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
[TBL] [Abstract][Full Text] [Related]
36. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient: A case report.
Nakashima R; Nishihara M; Iyonaga T; Iwasaka S; Yamamoto Y; Shono Y; Maki J; Tokuda K; Akahoshi T; Higo T; Kitazono T; Tsutsui H
Medicine (Baltimore); 2021 Jun; 100(23):e26313. PubMed ID: 34115042
[TBL] [Abstract][Full Text] [Related]
38. Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis.
Iapichino GE; Protti A; Andreis DT; Panigada M; Artoni A; Novembrino C; Pesenti A; Gattinoni L
ASAIO J; 2019; 65(3):257-263. PubMed ID: 29746315
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients.
Northam KA; Nguyen B; Chen SL; Sredzienski E; Charles A
J Pharm Pract; 2023 Feb; 36(1):79-86. PubMed ID: 34109859
[TBL] [Abstract][Full Text] [Related]
40. aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis.
Rajsic S; Treml B; Jadzic D; Breitkopf R; Oberleitner C; Bachler M; Bösch J; Bukumiric Z
J Crit Care; 2023 Oct; 77():154332. PubMed ID: 37244207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
